In addition to Fouremm, the July 31 interim financials Note 9 shows this.

"Private Placement and Amendment to License Agreement

In June 2020, the Company entered into a private placement with Newsoara to issue 3,333,334 common shares to Newsoara in tranches at a price of $1.50 per share for gross proceeds of $5.0 million. During the three months ended July 31, 2020, the first set of tranches closed and 2,000,001 common shares were issued at $1.50 per share for gross proceeds of $3.0 million. Subsequent to July 31, 2020, the Company issued 1,333,333 common shares at a price of $1.50 per share for gross proceeds of $2.0 million to Newsoara, in connection with the final tranche of the June 2020 private placement."

The first tranche shows in the cash flows from financing and the second will show there in the Oct. 31 interim financials.

Zenith has been paying RVX aproxiamtely $1 million annually for office and lab space and equipment as well as wages. This would say that they probably accrued about $250,000 in the July 31 quarter. They lowered what they owed RVX by $447,000 so together, this probably means that this tranche allowed them to pay RVX almost $700,000 during the quarter.